Christine Livingston

Title: Christine Livingston: Innovator in Gene Therapy

Introduction

Christine Livingston is a prominent inventor based in Lambertville, NJ (US). She has made significant contributions to the field of gene therapy, particularly in the treatment of Wilson disease. Her innovative work has the potential to improve the lives of many individuals affected by this condition.

Latest Patents

Christine holds a patent for "Gene therapy constructs for treating Wilson disease." This application relates to adeno-associated viral vectors encoding a truncated yet functional ATP7B for use in gene therapy for treating Wilson disease (WD). The truncated ATP7B described herein has several advantages over the wild-type ATP7B, such as higher efficacy and improved manufacturing yield. This patent highlights her commitment to advancing medical science and finding effective treatments for genetic disorders.

Career Highlights

Christine is currently employed at Ultragenyx Pharmaceutical Inc., where she continues to work on groundbreaking research in gene therapy. Her role at the company allows her to collaborate with other experts in the field and contribute to the development of innovative therapies.

Collaborations

One of her notable coworkers is Samuel C. Wadsworth, with whom she collaborates on various projects related to gene therapy. Their combined expertise enhances the research efforts at Ultragenyx Pharmaceutical Inc.

Conclusion

Christine Livingston is a dedicated inventor whose work in gene therapy is paving the way for new treatments for Wilson disease. Her innovative approach and commitment to research exemplify the impact that inventors can have on healthcare and medical advancements.